Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...

TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

在其他近期新闻中，TransMedics Group的股票评级经历了多次变化。摩根大通将该医疗技术公司从增持下调至中性，并将目标价从之前的116美元下调至75美元。这一调整是由于2024年表现喜忧参半以及短期前景谨慎，尽管公司长期增长潜力显著。与此同时，Piper Sandler维持对该股票的增持评级，但将目标价从110.00美元调整至90.00美元。

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

TransMedics（TMDX）是一家在器官移植技术领域占据领先地位的公司，自2022年初至2024年中，该公司销售额连续10个财季增长超过100%。然而，最新一财季的收入增长率仅为64%，并且公司对于即将到来的第四财季下调了35%的增长预期，这使 ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

周一，派杰桑德勒 (Piper Sandler)分析师Matt O'Brien维持对专注于器官移植技术的TransMedics Group (NASDAQ:TMDX)的"增持"评级和90.00美元的目标价。O'Brien的乐观态度基于该公司近期的表现指标，包括器官移植量和TransMedics医疗专机机队的活动。

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...